LDN Social Media
Get connected with us on social networks
Dr Pamela Smith, LDN Specialist and Advisor to the LDN Research Trust
Severe Chronic Fatigue
Would your protocol be the same for severe chronic fatigue?
It wouldn't be the same. It would be similar. Chronic Fatigue Syndrome is an autoimmune disease. If you're really interested in looking at that picture further, I did an immune workshop that was just mine, actually for the American Academy of Anti-Aging Physicians (A4M). If you're interested in the workshop - it's online; you can email me and I'm happy to get you a discount, and taking it, it's not expensive. The first two hours is what the immune system is, and then part of what you heard today, the second two hours are 10 ways to build the immune system without causing autoimmune disease. The third two hours is autoimmune diseases caused by infection. There are a number of autoimmune diseases, from rheumatoid arthritis to MS, to looking at the disease we're looking at here, COVID, that are reactivation of Epstein-Barr, and maybe also cytomegalovirus. So I go through that during those two hours. We also meet every month, online, to discuss what we're finding on COVID. So email me at faafm63@yahoo.com, and that has all the references that you would need in looking at that. But to answer your question, Chronic Fatigue Syndrome is a mitochondrial illness, so I certainly start with taking the patient off of gluten to fix the gut, and low dose naltrexone, then the mitochondria. We've had a great response with CovidRx. It’s over the counter. If you want the name of the rep, then email me and I'm happy to get that to you. You will get a better cost if you email me, and I send you the rep’s name than if you just try and order it on your own.
A Question from the Low Dose Naltrexone (LDN) Q&A Webinar on COVID and Long Haulers, the 2-hour seminar is available along with an extensive 278 page PowerPoint PDF and a Treatment Protocol, https://www.ldnrtevents.com/collections/webinars-and-training-courses/p…
Dr Pamela Smith, LDN Specialist and Advisor to the LDN Research Trust